Autolus Therapeutics to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8

LONDON, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc AUTL, a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its second quarter 2019 financial results and operational highlights before open of U.S. markets on Thursday, August 8, 2019.

Management will host a conference call at 8:30 a.m. ET/1:30 p.m. BST the same day to discuss the company's financial results and provide a general business update. To listen to the webcast and view the accompanying slide presentation, please go to: https://www.autolus.com/investor-relations/news-events/events.

The call may also be accessed by dialing (866) 679-5407 for U.S. and Canada callers or (409) 217-8320 for international callers. Please reference conference ID 2763978 . After the conference call, a replay will be available for one week. To access the replay, please dial (855) 859-2056 for U.S. and Canada callers or (404) 537-3406 for international callers. Please reference conference ID 2763978.

About Autolus Therapeutics plc

Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize cancer cells, break down their defense mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors. For more information, go to: https://www.autolus.com.

Investor relations contact:

Susan A. Noonan

S.A. Noonan Communications

+1-212-966-3650

susan@sanoonan.com

Media contact:

Silvia Taylor

Vice President, Corporate Affairs and Communications, Autolus

+1-240-801-3850

s.taylor@autolus.com

Media contact (UK):

Julia Wilson

JW Communications

+44 (0) 7818 430877

juliawilsonuk@gmail.com

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!